Article
BULLETIN OF THE
ISSN (Print) 0253-2964 | (Online) 1229-5949
KOREAN CHEMICAL SOCIETY
Fisher Scientific (Hampton, NH, USA) and Merck
(Kenilworth, NJ, USA). Trifluoroacetic acid (TFA) was
obtained from Acros Organics (Geel, Belgium). The deriva-
tizing agent, FMOC chloride, was procured from the Fluka
Company (Buchs, Switzerland). All racemic amino acids
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Racemic and/or L-amino acid methyl esters of norleucine,
norvaline, phenylalanine, serine, leucine, and valine were
obtained from Chem-Impex International (Bensenville, IL,
USA), Advanced ChemTech (Louisville, KY, USA), Acros
Organics (Geel, Belgium), Bachem (Bubendorf, Switzer-
land), and Alfa-Aesar (Haverhill, MA, USA). The other
racemic and L-amino acid methyl esters were purchased
from Sigma-Aldrich. Two commercially available FMOC
D- and L-phenylglycine, were purchased from the Fluka
Company (Buchs, Switzerland). The N-FMOC derivatized
racemic and L-amino acids and methyl esters were prepared
according to conventional methods.22 Racemic or L-
α-amino acid (5 mmol) was dissolved in 10% aqueous
sodium carbonate solution (12.5 mmol). Dioxane (7.5 mL)
was then added and the mixture was stirred in an ice-bath.
After that, 9-FMOC chloride (5 mmol) was added slowly
and stirred at room temperature for 5 h. Now, the reaction
mixture was poured into water and extracted with ether.
The aqueous solution obtained was acidified with c-HCl in
an ice-bath. Finally, the resulting N-FMOC α-amino acid
was filtered and dried under vacuum. In order to prepare
racemic or L-FMOC α-amino acid methyl ester, the corre-
sponding FMOC α-amino acid (1 mmol) synthesized in the
previous step was dissolved in 5 mL of anhydrous metha-
nol with N,N0-dicyclohexylcarbodiimide (1.1 mmol). The
mixture was stirred at room temperature for 12 h, filtered
and dried under vacuum to get N-FMOC α-amino acid
methyl ester.
injector, and an HP 1046A programmable fluorescence
detector. The chromatographic analysis was performed
under simultaneous UV 262 nm and fluorescence [excita-
tion (Ex.) 264 and emission (Em.) 312 nm] detection. All
enantiomeric separations of α-amino acids and methyl esters
as N-FMOC derivatives were performed using isocratic
mobile phases [10 or 20% 2-propanol/hexane (v/v) with or
without 0.1% TFA] at an ambient temperature (approximately
25 ꢀC) with a flow rate of 1 mL/min. Three covalently
bonded CSPs, CSP 1 (Chiralpak ID), CSP 2 (Chiralpak IE),
and CSP 3 (Chiralpak IF) (250 mm × 4.6 mm, I.D., 5 μm)
having chiral selectors of amylose tris (3-chlorophenylcarba-
mate), amylose tris (3,5-dichlorophenylcarbamate), and amy-
lose tris (3-chloro-4-methylphenylcarbamate), respectively,
were purchased from the Daicel Company (Tokyo, Japan).
Results and Discussion
Enantiomeric Separation of α-Amino acids and Methyl
Esters as N-FMOC Derivatives. The enantiomeric sepa-
ration results of nine α-amino acids and methyl esters as N-
FMOC derivatives with normal phase eluents on three
newly developed immobilized CSPs are summarized in
Tables 1–3. The conventional mobile phase system (2-pro-
panol/hexane) was used for the entire enantiomeric
separation process. The chromatographic parameters of
enantioseparation and retention factor were significantly
influenced by the nature of the mobile phase, the used CSP,
and the analyte type.12,18 Based on the overall results from
the nine analytes, the most successful chiral CSP was CSP
1 having amylose tris (3-chlorophenylcarbamate) as a chiral
selector except for two analytes of amino acids (entries
2 and 9, Table 1). Conversely, CSP 3 with amylose tris
(3-chloro-4-methylphenylcarbamate) showed the lowest
enantioselection and resolution of the investigated analytes,
as shown in Table 3. In general, the enantioseparation
results obtained from CSP 2 were lower than those
Liquid Chromatography. Analysis was performed using
an HP series 1100 HPLC system (Palo Alto, CA, USA),
consisting of a G1310A iso pump, an automatic sample
Table 1. Separation of the enantiomers of α-amino acids and methyl esters as N-FMOC derivatives on CSP 1.
FMOC amino acid FMOC amino acid methyl ester
Entry
Analyte
α
k01
Rs
Conf.
α
k01
Rs
Conf.
1
2
3
4
5
6
7
8
9
Alanine
Leucine
1.37
1.00
1.75
1.12
1.07
1.19
1.32
1.31
1.07
2.67
2.22
5.21
2.19
2.49
3.33
5.80
6.06a
2.20
5.18
—
L
—
L
L
L
L
L
L
D
3.68
1.74
4.03
2.85
2.32
1.36
1.65
2.14
1.61
5.03
3.22
5.84a
3.72
4.06
6.16
7.94
5.09
3.42
20.99
6.50
15.48
12.50
13.02
5.43
7.36
11.19
6.08
L
L
L
L
L
L
L
L
L
Methionine
Norleucine
Norvaline
Phenylalanine
Phenylglycine
Serine
9.56
1.50
1.21
3.21
4.52
4.11
0.83
Valine
Mobile phase: 10% 2-propanol/hexane (v/v) with 0.1% TFA for FMOC amino acids and 10% 2-propanol/hexane (v/v) for FMOC amino acid
methyl esters, flow rate: 1 mL/min, UV: 262 nm, fluorescence detection: Ex. 264 nm, Em. 312 nm, k01: retention factor of the first eluted
enantiomer, α: separation factor, Rs: resolution factor, Conf.: the absolute configuration of the second eluted enantiomer.
a20% 2-propanol/hexane (v/v) with or without 0.1% TFA.
Bull. Korean Chem. Soc. 2019
© 2019 Korean Chemical Society, Seoul & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2